Serum copeptin levels in adolescents with primary hypertension

Pediatric Nephrology

Volumn 29, Issue 3, 2014, Pages 423-429

  Tenderenda Banasiuk, Edyta ^a   Wasilewska, Anna ^a   Filonowicz, Renata ^a   Jakubowska, Urszula ^a   Waszkiewicz Stojda, Marlena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adolescents; Copeptin; Hypertension

Indexed keywords

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPEPTIDES; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEX FACTORS; UP-REGULATION; WHITE COAT HYPERTENSION;

EID: 84894227570     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2683-5     Document Type: Article

References (42)

1. Rosner B, Cook NR, Daniels S, Falkner B (2013) Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension 62(2):247-254
2. Ostchega Y, Carroll M, Prineas RJ, McDowell MA, Louis T, Tilert T (2009) Trends of elevated blood pressure among children and adolescents: data from the National Health and Nutrition Examination Survey 1988-2006. Am J Hypertens 22(1):59-67
3. Lurbe E (2013) Childhood blood pressure: trends and future tracks. Hypertension 62(2):242-243
4. Burn JH (1934) The control of the blood-pressure: (Section of Therapeutics and Pharmacology). Proc R Soc Med 28(1):15-28
5. Krakoff LR, Elijovich F, Barry C (1985) The role of vasopressin in experimental and clinical hypertension. Am J Kidney Dis 5(4):A40-A47
6. Kawano Y, Matsuoka H, Nishikimi T, Takishita S, Omae T (1997) The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. Am J Hypertens 10(11):1240-1244 (Pubitemid 28005346)
7. Padfield PL, Brown JJ, Lever AF, Morton JJ, Robertson JI (1981) Does vasopressin play a role in the pathogenesis of hypertension? Clin Sci (Lond) 61(7):141-143
8. Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H (1997) Role of vasopressin in essential hypertension: racial differences. J Hypertens 15(5):545-550 (Pubitemid 27216014)
9. De Paula RB, Plavnik FL, Rodrigues CIS, De Rochad Neves AF, Kohlmann O Jr, Ribeiro AB, Gavras I, Gavras H (1993) Contribution of vasopressin to orthostatic blood pressure maintenance in essential hypertension. Am J Hypertens 6(9):794-798 (Pubitemid 23290750)
10. Gavras H (1990) Pressor systems in hypertension and congestive heart failure. Role of vasopressin. Hypertension 16(5):587-593 (Pubitemid 20368349)
11. Argent NB, Burrell LM, Goodship TH, Wilkinson R, Baylis PH (1991) Osmoregulation of thirst and vasopressin release in severe chronic renal failure. Kidney Int 39(2):295-300, 13
12. Aoyagi T, Koshimizu TA, Tanoue A (2009) Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice. Kidney Int 76(10):1035-1039
13. Littlejohn NK, Siel RB Jr, Ketsawatsomkron P, Pelham CJ, Pearson NA, Hilzendeger AM, Buehrer BA, Weidemann BJ, Li H, Davis DR, Thompson AP, Liu X, Cassell MD, Sigmund CD, Grobe JL (2013) Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent. Am J Physiol Regul Integr Comp Physiol 304(10):R818-R828
14. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52(1):112-119 (Pubitemid 43032474)
15. Keane WF, Eknoyan G (1999) Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33(5):1004-1010 (Pubitemid 29214705)
16. Enhörning S, Struck J, Wirfält E, Hedblad B, Morgenthaler NG, Melander O (2011) Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab 96(7):E1065-E1072
17. Enhörning S, Bankir L, Bouby N, Struck J, Hedblad B, Persson M, Morgenthaler NG, Nilsson PM, Melander O (2013) Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective malmö diet and cancer study cardiovascular cohort. Int J Obes 37(4):598-603
18. Przybylowski P, Malyszko J, Malyszko JS (2010) Copeptin in heart transplant recipients depends on kidney function and intraventricular septal thickness. Transplant Proc 42(5):1808-1811
19. Li X, Yang XC, Sun QM, Chen XD, Li YC (2013) Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease. Chin Med J (Engl) 126(5):823-827
20. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, Mahoney L, McCrindle B, Mietus-Snyder M, Steinberger J, Daniels S (2008) Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 52(3):433-451
21. Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11(10):1305-1319
22. Kułaga Z, Litwin M, Grajda A, Kułaga K, Gurzkowska B, GóÅdÅ M, Pan H, Study OLAF (2010) Oscillometric blood pressure percentiles for Polish normal-weight school-aged children and adolescents. Group. J Hypertens 30(10):1942-1954
23. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995-2007 (Pubitemid 35305497)
24. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629-637
25. Yoon EY, Cohn L, Rocchini A, Kershaw D, Freed G, Ascione F, Clark S (2012) Antihypertensive prescribing patterns for adolescents with primary hypertension. Pediatrics 129:e1-e8
26. Nalbantoǧlu B, YazIcI CM, Nalbantoǧlu A, Güzel S, Topçu B, Güzel EC, Donma MM, Ozdilek B, Mintaş NE (2013) Copeptin as a novel biomarker in nocturnal enuresis. Urology 4295(13):00819-4
27. Baltatu O, Campos LA, Bader M (2004) Genetic targeting of the brain renin-angiotensin system in transgenic rats: impact on stress-induced renin release. Acta Physiol Scand 181(4):579-584 (Pubitemid 39078857)
28. Bonjour JP, Malvin RL (1970) Stimulation of ADH release by the renin-angiotensin system. Am J Physiol 218(6):1555-1559
29. Coleman CG, Anrather J, Iadecola C, Pickel VM (2009) Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus. Neuroscience 163(1):129-142
30. Itaya Y, Suzuki H, Matsukawa S, Kondo K, Saruta T (1986) Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am J Physiol 251(2 Pt 2):H261-H268
31. Grobe JL, Xu D, Sigmund CD (2008) An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda) 23:187-193
32. Head GA, Mayorov DN (2001) Central angiotensin and baroreceptor control of circulation. Ann N Y Acad Sci 940:361-379 (Pubitemid 32623408)
33. Mutig K, Paliege A, Kahl T, Jöns T, Müller-Esterl W, Bachmann S (2007) Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol 293(4):F1166-F1177 (Pubitemid 47583950)
34. Aoyagi T, Izumi Y, Hiroyama M, Matsuzaki T, Yasuoka Y, Sanbe A, Miyazaki H, Fujiwara Y, Nakayama Y, Kohda Y, Yamauchi J, Inoue T, Kawahara K, Saito H, Tomita K, Nonoguchi H, Tanoue A (2008) Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am J Physiol Renal Physiol 295(1):F100-F107
35. Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L (2008) Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol 19(9):1721-1731
36. Bankir L, Bichet DG, Bouby N (2010) Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension? Am J Physiol Renal Physiol 299(5):F917-F928
37. Bankir L (2001) Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 51(3):372-390 (Pubitemid 32718586)
38. Whitton PD, Rodrigues LM, Hems DA (1978) Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions. Biochem J 176(3):893-898 (Pubitemid 9090472)
39. Keppens S, de Wulf H (1979) The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis. Biochim Biophys Acta 588(1):63-69 (Pubitemid 10188250)
40. Rofe AM, Williamson DH (1983) Mechanism for the 'anti-lipolytic' action of vasopressin in the starved rat. Biochem J 212(3):899-902 (Pubitemid 13056911)
41. Saleem U, Khaleghi M, Morgenthaler NG, Bergmann A, Struck J, Mosley TH Jr, Kullo IJ (2009) Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab 94(7):2558-2564
42. Rossi R, Scharrer E (1993) Mechanisms of the effects of vasopressin on plasma levels of free fatty acids and triglycerides in pygmy goats. Comp Biochem Physiol Comp Physiol 104(2):287-290 (Pubitemid 23045628)